Abstract
Enzymes are biocatalysts that have found profound applications in the current biotherapeutic industry and play a crucial role in diagnosis, prevention, and biochemical analysis of major diseases. However, stability, protein degradation and immunogenicity in the body present unique challenges that are faced upon sustained use of such enzymes. The present chapter is an attempt to dissect the state-of-the-art in relation to the challenges of development of therapeutic enzymes and the recent advances to address them. At the very outset, diseases where enzymes have found effective applications and the various causes of enzyme instability have been discussed. In recent times, polymer or nano- conjugated resistant delivery methods, as well as mutagenesis have led to manifold increase in enzyme stability against thermal denaturation, acidic gut environment, proteolysis and immunogenicity. Further, methods of analytical characterization of proteins have been highlighted and explored to shape future research directions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- US:
-
United States
- FDA:
-
Food and drug administration
- AML:
-
Acute Myeloid Leukemia
- ALL:
-
Acute Lymphoblastic Leukemia
- PEG:
-
Polyethylene glycol
- ADP:
-
Adenosine Diphosphate
- NAD:
-
Nicotinamide Adenine Dinucleotide
- ERT:
-
Enzyme Replacement Therapy
- GAG:
-
Glucosaminoglycans
- DNA:
-
Deoxyribonucleic Acid
- LAL:
-
Lysosomal Acid Lipase
- MPS:
-
Mucopolysaccharidosis
- LIPA:
-
Lysosomal Acid Lipase
- SCID:
-
Severe Combined Immune Deficiency
- ADA:
-
Adenosine Deaminase
- PPFE:
-
Pleuroparenchymal Fibroelastosis
- RNA:
-
Ribonucleic Acid
- DUB:
-
Deubiquitinating Enzyme
- GI:
-
Gastrointestinal
- BAb:
-
Binding Antibodies
- GD:
-
Gaucher’s Disease
- GALK1:
-
Galactokinase 1
- EC:
-
Enzyme Commission
- ATP:
-
Adenosine Triphosphate
- ABD:
-
Albumin-Binding Domain
- PVP:
-
Poly(N-vinylpyrrolidone)
- LbL:
-
Layer-by-layer
- MNP:
-
Magnetic Nanoparticles
- PAGE:
-
Poly-Acrylamide Gel Electrophoresis
- SDS:
-
Sodium Dodecyl Sulfate
- IEF:
-
Isoelectric Focusing
- 2D:
-
2-dimension
- DIGE:
-
Difference Gel Electrophoresis
- HPLC:
-
High-performance liquid chromatography
- CD:
-
Circular Dichroism
- NMR:
-
Nuclear Magnetic Resonance
- XRD:
-
X-ray Diffraction
- FTIR:
-
Fourier-Transform Infrared Spectroscopy
- IR:
-
Infrared
- DLS:
-
Dynamic Light Scattering
- HT-DLS:
-
High- Throughput Dynamic Light Scattering
- UVRR:
-
Ultraviolet Resonance Raman
- ROA:
-
Raman Optical Activity
- ANS:
-
8-Anilinonaphthalene-1-sulfonic acid
- ThT:
-
Thioflavin-T
- TEM:
-
Transmission Electron Microscopy
- ELISA:
-
Enzyme-Linked Immunosorbent Assay
- SPR:
-
Surface Plasmon Resonance
- BLI:
-
Bio-Layer Interferometry
- ITC:
-
Isothermal Titration Calorimetry
- tPa:
-
Tissue Plasminogen Activator
- SKA:
-
Streptokinase
References
Akash MSH, Rehman K, Tariq M, Chen S (2015) Development of therapeutic proteins: advances and challenges. Turk J Biol 39(3):343–358
Alain K, Querellou J (2009) Cultivating the uncultured: limits, advances and future challenges. Extremophiles 13(4):583–594
Alegra T, Vairo F, de Souza MV, Krug BRC, Schwartz IVD (2012) Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis. Genet Mol Biol 35(4):947–954
Alpers D (2008) Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target. Futur Lipidol 3(4):385–397
Anderson VL, Webb WW (2011) Transmission electron microscopy characterization of fluorescently labelled amyloid β 1-40 and α-synuclein aggregates. BMC Biotechnol 11(1):125
Angelini C, Semplicini C (2012) Enzyme replacement therapy for Pompe disease. Curr Neurol Neurosci Rep 12(1):70–75
Baker EN, Hubbard RE (1984) Hydrogen bonding in globular proteins. Prog Biophys Mol Biol 44(2):97–179
Bakshi RP, Shapiro TA (2003) DNA topoisomerases as targets for antiprotozoal therapy. Mini-Rev Med Chem 3(6):597–608
Balci H, Ozturk MT, Pijning T, Ozturk SI, Gumusel F (2014) Improved activity and pH stability of E. coli ATCC 11105 penicillin acylase by error-prone PCR. Appl Microbiol Biotechnol 98(10):4467–4477
Berkowitz SA (2017) Analytical characterization: structural assessment of biosimilarity. In: Biosimilar drug product development. CRC Press, Boca Raton, pp 15–82
Bui LA, Hurst S, Finch GL, Ingram B, Jacobs IA, Kirchhoff CF, Ng CK, Ryan AM (2015) Key considerations in the preclinical development of biosimilars. Drug Discov Today 20:3–15
Burley SK, Petsko GA (1988) Weakly polar interactions in proteins. In: Advances in protein chemistry. Elsevier, New York, pp 125–189
But WM, Wong MY, Chow JC, Chan WKY, Ko WT, Wu SP, Wong ML, Miu TY, Tse WY, Hung WWY (2011) Enzyme replacement therapy for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): experience in Hong Kong. Hong Kong Med J 17(4):317–324
Calvo-Lerma J, Martínez-Barona S, Masip E, Fornés V, Ribes-Koninckx C (2017) Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption. Rev Esp Enferm Dig Organo Oficial Soc Esp Patol Dig 109(10):684–689
Cavalli A, Salvatella X, Dobson CM, Vendruscolo M (2007) Protein structure determination from NMR chemical shifts. Proc Natl Acad Sci 104(23):9615–9620
Chabot JA, Tsai WY, Fine RL, Chen C, Kumah CK, Antman KA, Grann VR (2010) Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. J Clin Oncol 28(12):2058
Chan B, Wara D, Bastian J, Hershfield MS, Bohnsack J, Azen CG, Parkman R, Weinberg K, Kohn DB (2005) Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID). Clin Immunol 117(2):133–143
Chibale K (2002) Towards broadspectrum antiprotozoal agents. Arkivoc 9:93–98
Chorny M, Hood E, Levy RJ, Muzykantov VR (2010) Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles. J Control Release 146(1):144–151
Choudhary B, Nagpure A, Gupta RK (2014) Fungal cell-wall lytic enzymes, antifungal metabolite (s) production, and characterization from Streptomyces exfoliatus MT9 for controlling fruit-rotting fungi. J Basic Microbiol 54(12):1295–1309
Chuang HY, Suen CS, Hwang MJ, Roffler SR (2015) Toward reducing immunogenicity of enzyme replacement therapy: altering the specificity of human β-glucuronidase to compensate for α-iduronidase deficiency. Protein Eng Des Sel 28(11):519–530
Cocci A, Russo GI, Briganti A, Salonia A, Cacciamani G, Capece M, Falcone M, Timpano M, Cito G, Verze P (2018) Predictors of treatment success after collagenase clostridium histolyticum injection for Peyronie’s disease. Development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study. BJU Int 122:680–687
Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV (2012) Microencapsulation of probiotics for gastrointestinal delivery. J Control Release 162(1):56–67
Da Silva EM, Strufaldi MW, Andriolo RB, Silva LA (2011) Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). Cochrane Database Syst Rev 11(11)
DeLong RK, Reynolds CM, Malcolm Y, Schaeffer A, Severs T, Wanekaya A (2010) Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules. Nanotechnol Sci Appl 3:53
Desai UR (2004) New antithrombin-based anticoagulants. Med Res Rev 24(2):151–181
Doig AJ, Williams DH (1991) Is the hydrophobic effect stabilizing or destabilizing in proteins?: The contribution of disulphide bonds to protein stability. J Mol Biol 217(2):389–398
Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel A-M, Vilmer E (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children’s Leukemia Group phase 3 trial. Blood 99(8):2734–2739
Dziubla TD, Karim A, Muzykantov VR (2005) Polymer nanocarriers protecting active enzyme cargo against proteolysis. J Control Release 102(2):427–439
Egler RA, Ahuja SP, Matloub Y (2016) L-asparaginase in the treatment of patients with acute lymphoblastic leukemia. J Pharmacol Pharmacother 7(2):62
Ehren J, Govindarajan S, Morón B, Minshull J, Khosla C (2008) Protein engineering of improved prolyl endopeptidases for celiac sprue therapy. Protein Eng Des Sel 21(12):699–707
Fekete S, Guillarme D, Sandra P, Sandra K (2015) Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals. Anal Chem 88(1):480–507
Fuhrmann G, Leroux JC (2011) In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract. Proc Natl Acad Sci 108(22):9032–9037
Fuhrmann G, Leroux JC (2014) Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives. Pharm Res 31(5):1099–1105
Gámez A, Wang L, Straub M, Patch MG, Stevens RC (2004) Toward PKU enzyme replacement therapy: PEGylation with activity retention for three forms of recombinant phenylalanine hydroxylase. Mol Ther 9(1):124–129
Ghaffarinia A, Jalili C, Riazi-Rad F, Mostafaie A, Parvaneh S, Pakravan N (2014) Anti-inflammatory effect of chymotrypsin to autoimmune response against CNS is dose-dependent. Cell Immunol 292(1–2):102–108
Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60(11):1307–1315
Ghosh S, Tiwari R, Hemamalini R, Khare SK (2017) Multi-omic approaches for mapping interactions among marine microbiomes. In: Understanding host-microbiome interactions-an omics approach. Springer, pp 353–368
Ghosh S, Ahmad R, Gautam VK, Khare SK (2018) Cholesterol-oxidase-magnetic nanobioconjugates for the production of 4-cholesten-3-one and 4-cholesten-3, 7-dione. Bioresour Technol 254:91–96
Gökmen V (2015) Acrylamide in food: analysis, content and potential health effects. Academic, Amsterdam
Goodsell DS (2005) The molecular perspective: L-asparaginase. Oncologist 10(3):238–239
Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1(6):2876
Griswold KE, Bement JL, Teneback CC, Scanlon TC, Wargo MJ, Leclair LW (2014) Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections. Bioengineered 5(2):143–147
Hamuro Y, Coales SJ, Molnar KS, Tuske SJ, Morrow JA (2008) Specificity of immobilized porcine pepsin in H/D exchange compatible conditions. Rapid Commun Mass Spectrom 22(7):1041–1046
Harmatz P (2015) Enzyme replacement therapies and immunogenicity in lysosomal storage diseases: is there a pattern? Clin Ther 37(9):2130–2134
Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2(3):214
Haxho F, Neufeld RJ, Szewczuk MR (2016) Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis. Oncotarget 7(26):40860
Hayashi S, Yokoyama I, Namii Y, Emi N, Uchida K, Takagi H (1999) Inhibitory effect on the establishment of hepatic metastasis by transduction of the tissue plasminogen activator gene to murine colon cancer. Cancer Gene Ther 6(4):380
Hendsch ZS, Tidor B (1994) Do salt bridges stabilize proteins? A continuum electrostatic analysis. Protein Sci 3(2):211–226
Hershfield MS, Chaffee S, Sorensen RU (1993) Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy. Pediatr Res 33(S4):S42
Huynen C, Filée P, Matagne A, Galleni M, Dumoulin M (2013) Class a-lactamases as versatile scaffolds to create hybrid enzymes: applications from basic research to medicine. Biomed Res Int 2013:1–6
Ilinskaya ON, Mahmud RS (2014) Ribonucleases as antiviral agents. Mol Biol 48(5):615–623
Illanes A, Valencia P (2017) Industrial and therapeutic enzymes: penicillin acylase. In: Current developments in biotechnology and bioengineering. Elsevier, Amsterdam, pp 267–305
Imrie CW, Connett G, Hall RI, Charnley RM (2010) Enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Aliment Pharmacol Ther 32:1–25
Ishihara T, Tanaka KI, Tasaka Y, Namba T, Suzuki J, Ishihara T, Okamoto S, Hibi T, Takenaga M, Igarashi R (2009) Therapeutic effect of lecithinized superoxide dismutase against colitis. J Pharmacol Exp Ther 328(1):152–164
Jayachandran S, Khobre P (2017) Efficacy of bromelain along with trypsin, rutoside trihydrate enzymes and diclofenac sodium combination therapy for the treatment of TMJ osteoarthritis-a randomised clinical trial. J Clin Diagn Res 11(6):ZC09
Kaminetzky D, Hymes KB (2008) Denileukin diftitox for the treatment of cutaneous T-cell lymphoma. Biol Targets Ther 2(4):717
Karamitros CS, Yashchenok AM, Möhwald H, Skirtach AG, Konrad M (2013) Preserving catalytic activity and enhancing biochemical stability of the therapeutic enzyme asparaginase by biocompatible multilayered polyelectrolyte microcapsules. Biomacromolecules 14(12):4398–4406
Karstad R, Isaksen G, Wynendaele E, Guttormsen Y, De Spiegeleer B, Brandsdal BO, Svendsen JS, Svenson J (2012) Targeting the S1 and S3 subsite of trypsin with unnatural cationic amino acids generates antimicrobial peptides with potential for oral administration. J Med Chem 55(14):6294–6305
Kasturi L, Amin Alpa S (2001) Enzyme replacement therapy in Gaucher’s disease. Indian Pediatr 38(6):686–687
Kini RM (2005) Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms. Toxicon 45(8):1147–1161
Kishimoto TK, Ferrari JD, LaMothe RA, Kolte PN, Griset AP, O'Neil C, Chan V, Browning E, Chalishazar A, Kuhlman W (2016) Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles. Nat Nanotechnol 11(10):890
Knappe D, Goldbach T, Hatfield MPD, Palermo NY, Weinert S, Sträter N, Hoffmann R, Lovas SN (2016) Proline-rich antimicrobial peptides optimized for binding to Escherichia coli chaperone DnaK. Protein Pept Lett 23(12):1061–1071
Kong J, Yu S (2007) Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochim Biophys Sin 39(8):549–559
Kosky AA, Razzaq UO, Treuheit MJ, Brems DN (1999) The effects of alpha-helix on the stability of Asn residues: deamidation rates in peptides of varying helicity. Protein Sci 8(11):2519–2523
Krizsan A, Volke D, Weinert S, Sträter N, Knappe D, Hoffmann R (2014) Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70 S ribosome. Angew Chem Int Ed 53(45):12236–12239
Lamppa JW, Griswold KE (2013) Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy. Antimicrob Agents Chemother 57(1):137–145
Langer V, Bhandari PS, Rajagopalan S, Mukherjee MK (2013) Enzymatic debridement of large burn wounds with papain-urea: is it safe? Med J Armed Forces India 69(2):144–150
Lansigan F, Stearns DM, Foss F (2010) Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma. Cancer Manag Res 2:53
Lee HR, Kim MI, Hong SE, Choi J, Kim YM, Yoon KR, Lee S, Ha SH (2016) Effect of functional group on activity and stability of lipase immobilized on silica-coated magnetite nanoparticles with different functional group. Anal Sci Technol 29(3):105–113
Leland PA, Raines RT (2001) Cancer chemotherapy-ribonucleases to the rescue. Chem Biol 8(5):405–413
Li YM, Vallera DA, Hall WA (2013) Diphtheria toxin-based targeted toxin therapy for brain tumors. J Neuro-Oncol 114(2):155–164
Liao AY, Ghosh A, O’Leary C, Mercer J, Church HJ, Tylee KL, Goenka A, Holley R, Wynn RF, Jones SA (2018) Induction of immune tolerance to enzyme replacement therapy in mucopolysaccharidosis type I. Mol Genet Metab 123(2):S86
Lindgren J, Eriksson Karlström A (2014) Intramolecular thioether crosslinking of therapeutic proteins to increase proteolytic stability. ChemBioChem 15(14):2132–2138
Lu F, Lu Z, Bie X, Yao Z, Wang Y, Lu Y, Guo Y (2010) Purification and characterization of a novel anticoagulant and fibrinolytic enzyme produced by endophytic bacterium Paenibacillus polymyxa EJS-3. Thromb Res 126(5):e349–e355
Luo Q, Joubert MK, Stevenson R, Ketchem RR, Narhi LO, Wypych J (2011) Chemical modifications in therapeutic protein aggregates generated under different stress conditions. J Biol Chem 286(28):25134–25144
Lyseng-Williamson KA (2014) Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome). BioDrugs 28(5):465–475
Mali N, Wavikar P, Vavia P (2015) Serratiopeptidase loaded chitosan nanoparticles by polyelectrolyte complexation: in vitro and in vivo evaluation. AAPS PharmSciTech 16(1):59–66
Matuszewska A, Karp M, Jaszek M, Janusz G, Osińska-Jaroszuk M, Sulej J, Stefaniuk D, Tomczak W, Giannopoulos K (2016) Laccase purified from Cerrena unicolor exerts antitumor activity against leukemic cells. Oncol Lett 11(3):2009–2018
McAuley M, Mesa-Torres N, McFall A, Morris S, Huang M, Pey A, Timson DJ (2018) Improving the activity and stability of human galactokinase for therapeutic and biotechnological applications. ChemBioChem 19:1088–1095
McDonald IK, Thornton JM (1994) Satisfying hydrogen bonding potential in proteins. J Mol Biol 238(5):777–793
Mitulović G, Mechtler K (2006) HPLC techniques for proteomics analysis-a short overview of latest developments. Brief Funct Genomics 5(4):249–260
Mohan Kumar NS, Kishore V, Manonmani HK (2014) Chemical modification of L-asparaginase from Cladosporium sp. for improved activity and thermal stability. Prep Biochem Biotechnol 44(5):433–450
Mouneshkumar Chappi D, Suresh KV, Patil MR, Desai R, Tauro DP, Shiva Bharani KNS, Parkar MI, Babaji HV (2015) Comparison of clinical efficacy of methylprednisolone and serratiopeptidase for reduction of postoperative sequelae after lower third molar surgery. J Clin Exp Dent 7(2):e197
Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M (2006) A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 8(8):465
Nanduri B, Suvarnapunya AE, Venkatesan M, Edelmann MJ (2013) Deubiquitinating enzymes as promising drug targets for infectious diseases. Curr Pharm Des 19(18):3234–3247
Nebija D, Noe CR, Urban E, Lachmann B (2014) Quality control and stability studies with the monoclonal antibody, trastuzumab: application of 1D-vs. 2D-gel electrophoresis. Int J Mol Sci 15(4):6399–6411
Neurath H (1984) Evolution of proteolytic enzymes. Science 224(4647):350–357
Ngu LH, Peitee WO, Leong HY, Chew HB (2017) Case report of treatment experience with idursulfase beta (Hunterase) in an adolescent patient with MPS II. Mol Genet Metab Rep 12:28–32
Nukolova NV, Aleksashkin AD, Abakumova TO, Morozova AY, Gubskiy IL, Kirzhanova EA, Abakumov MA, Chekhonin VP, Klyachko NL, Kabanov AV (2018) Multilayer polyion complex nanoformulations of superoxide dismutase 1 for acute spinal cord injury. J Control Release 270:226–236
Nupur N, Chhabra N, Dash R, Rathore AS (2018) Assessment of structural and functional similarity of biosimilar products: rituximab as a case study. Translated by Taylor & Francis, pp 143–158
Pattnaik P (2005) Surface plasmon resonance. Appl Biochem Biotechnol 126(2):79–92
Perchellet EM, Wang Y, Weber RL, Lou K, Hua DH, Perchellet JPH (2004) Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and-9 in HL-60 cells by a mechanism which does not involve Fas signaling. Anti-Cancer Drugs 15(10):929–946
Pierce MM, Raman CS, Nall BT (1999) Isothermal titration calorimetry of protein-protein interactions. Methods 19(2):213–221
Pundir CS, Narang J, Chauhan N, Sharma P, Sharma R (2012) An amperometric cholesterol biosensor based on epoxy resin membrane bound cholesterol oxidase. Indian J Med Res 136(4):633
Qi Y, Chilkoti A (2015) Protein-polymer conjugation-moving beyond PEGylation. Curr Opin Chem Biol 28:181–193
Ramirez Peña E, Treviño J, Liu Z, Perez N, Sumby P (2010) The group A Streptococcus small regulatory RNA FasX enhances streptokinase activity by increasing the stability of the ska mRNA transcript. Mol Microbiol 78(6):1332–1347
Rathore AS (2009) Follow-on protein products: scientific issues, developments and challenges. Trends Biotechnol 27(12):698–705
Reed GL, Liu L, Houng AK, Matsueda LH, Lizbeth H (1998) Mechanisms of fibrin-independent and fibrin-dependent plasminogen activation by streptokinase. Circulation 98(17):41–41
Reichel C, Thevis M (2013) Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin. Bioanalysis 5(5):587–602
Rosenberg M, Kingma W, Fitzpatrick MA, Richards SM (1999) Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration. Blood 93(6):2081–2088
Rosenberg L, Lapid O, Bogdanov-Berezovsky A, Glesinger R, Krieger Y, Silberstein E, Sagi A, Judkins K, Singer AJ (2004) Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report. Burns 30(8):843–850
Sabu A (2003) Sources, properties and applications of microbial therapeutic enzymes. Indian J Biotechnol 2(2003):334–341
Sarada KV (2013) Production and applications of L-glutaminase using fermentation technology. Asia Pac J Res 1:1
Saunders SE, Bartz JC, Vercauteren KC, Bartelt-Hunt SL (2011) An enzymatic treatment of soil-bound prions effectively inhibits replication. Appl Environ Microbiol 77(13):4313–4317
Sawhney P, Kumar S, Maheshwari N, Singh Guleria S, Dhar N, Kashyap R, Sahni G (2016) Site-specific thiol-mediated PEGylation of streptokinase leads to improved properties with clinical potential. Curr Pharm Des 22(38):5868–5878
Scagnolari C, Bellomi F, Turriziani O, Bagnato F, Tomassini V, Lavolpe V, Ruggieri M, Bruschi F, Meucci G, Dicuonzo G (2002) Neutralizing and binding antibodies to IFN-β: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-β preparations. J Interf Cytokine Res 22(2):207–213
Schöneich C (2000) Mechanisms of metal-catalyzed oxidation of histidine to 2-oxo-histidine in peptides and proteins. J Pharm Biomed Anal 21(6):1093–1097
Shah Mahmud R, Müller C, Romanova Y, Mostafa A, Ulyanova V, Pleschka S, Ilinskaya O (2017) Ribonuclease from Bacillus acts as an antiviral agent against negative-and positive-sense single stranded human respiratory RNA viruses. BioMed Res Int 2017
Shahaboddin ME, Khajeh K, Maleki M, Golestani A (2017) Improvement of activity and stability of chondroitinase ABC I by introducing an aromatic cluster at the surface of protein. Enzym Microb Technol 105:38–44
Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL (1990) Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci 87(23):9188–9192
Shaked ZE, Wolfe S (1988) Stabilization of pyranose 2-oxidase and catalase by chemical modification. In: Methods in enzymology, pp 599–615
Shlyakhovenko VO (2016) Ribonucleases. Possible new approach in cancer therapy. Exp Oncol 38(1):2–8
Sikri N, Bardia A (2007) A history of streptokinase use in acute myocardial infarction. Tex Heart Inst J 34(3):318
Some D, Burge R (2015) Innovations in automation-high-throughput dynamic light scattering for screening biotherapeutic formulations. Biopharm Int 28(11):23
Su K, Donaldson E, Sharma R (2016) Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa. Appl Clin Genet 9:157
Tanford C (1980) The hydrophobic effect: formation of micelles and biological membranes, 2nd edn. Wiley, Brisbane
Tatsumoto KM, Oh KK, Baker JO, Himmel ME (1989) Enhanced stability of glucoamylase through chemical crosslinking. Appl Biochem Biotechnol 20(1):293–308
Thurberg BL, Maloney CL, Vaccaro C, Afonso K, Tsai AC-H, Bossen E, Kishnani PS, O’Callaghan M (2006) Characterization of pre-and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Investig 86(12):1208
Tishchenko S, Gabdulkhakov A, Melnik B, Kudryakova I, Latypov O, Vasilyeva N, Leontievsky A (2016) Structural studies of component of lysoamidase bacteriolytic complex from Lysobacter sp. XL1. Protein J 35(1):44–50
Tiwari R, Nain L, Labrou NE, Shukla P (2018) Bioprospecting of functional cellulases from metagenome for second generation biofuel production: a review. Crit Rev Microbiol 44(2):244–257
Torchilin VP, Maksimenko AV, Smirknov VN, Berezin IV, Klibanov AM, Martinek K (1978) The principles of enzyme stabilization. III. The effect of the length of intra-molecular cross-linkages on thermostability of enzymes. Biochim Biophys Acta (BBA)-Enzymol 522(2):277–283
Tsuruta LR, Lopes dos Santos M, Moro AM (2015) Biosimilars advancements: moving on to the future. Biotechnol Prog 31(5):1139–1149
Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, Ahuja AA, Sharma M, Gautam A, Raghava GPS (2017) THPdb: database of FDA-approved peptide and protein therapeutics. PLoS One 12(7):e0181748
Vereshchagin IA, Vereshchagin SI, Zhuravleva OD (1985) Enhanced effectiveness of antibiotic therapy with an exogenous lysozyme in dysentery in children. Antibiot Med Biotekhnologiia Antibiot Med Biotechnol 30(12):927–931
Vidya J, Ushasree MV, Pandey A (2014) Effect of surface charge alteration on stability of l-asparaginase II from Escherichia sp. Enzym Microb Technol 56:15–19
Vivian JT, Callis PR (2001) Mechanisms of tryptophan fluorescence shifts in proteins. Biophys J 80(5):2093–2109
Wang D, Ichiyama RM, Zhao R, Andrews MR, Fawcett JW (2011) Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. J Neurosci 31(25):9332–9344
Wang H, Hagedorn J, Svendsen A, Borch K, Otzen DE (2013) Variant of the Thermomyces lanuginosus lipase with improved kinetic stability: a candidate for enzyme replacement therapy. Biophys Chem 172:43–52
Wang B, Ji SQ, Ma XQ, Lu M, Wang LS, Li FL (2018) Substitution of one calcium-binding amino acid strengthens substrate binding in a thermophilic alginate lyase. FEBS Lett 592(3):369–379
Wen Z-Q (2007) Raman spectroscopy of protein pharmaceuticals. J Pharm Sci 96(11):2861–2878
Wong SS, Wong L-JC (1992) Chemical crosslinking and the stabilization of proteins and enzymes. Enzym Microb Technol 14(11):866–874
Wu XC, Ye R, Duan Y, Wong S-L (1998) Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life. Appl Environ Microbiol 64(3):824–829
Yoo EH, Lee SY (2010) Glucose biosensors: an overview of use in clinical practice. Sensors 10(5):4558–4576
Zenatti PP, Migita NA, Cury NM, Mendes-Silva RA, Gozzo FC, de Campos-Lima PO, Yunes JA, Brandalise SR (2018) Low bioavailability and high immunogenicity of a new brand of E. coli-asparaginase with active host contaminating proteins. EBioMedicine 30:158–166
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ghosh, S., Alam, S., Rathore, A.S., Khare, S.K. (2019). Stability of Therapeutic Enzymes: Challenges and Recent Advances. In: Labrou, N. (eds) Therapeutic Enzymes: Function and Clinical Implications. Advances in Experimental Medicine and Biology, vol 1148. Springer, Singapore. https://doi.org/10.1007/978-981-13-7709-9_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-7709-9_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7708-2
Online ISBN: 978-981-13-7709-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)